ADC Therapeutics SA(ADCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADCT ADC Therapeutics SA

盘后交易 12-11 18:01:15 EST

4.18

+0.17

+4.24%

盘后4.18

+0.000.00%

17:39 EST

最高4.19	最低3.99	成交量111.26万
今开4.00	昨收4.01	日振幅4.99%
总市值5.18亿	流通市值3.86亿	总股本1.24亿
成交额456.75万	换手率1.21%	流通股本9,224万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADCT","market":"US","secType":"STK","nameCN":"ADC Therapeutics SA","latestPrice":4.18,"timestamp":1765486800000,"preClose":4.01,"halted":0,"volume":1112566,"hourTrading":{"tag":"盘后","latestPrice":4.18,"preClose":4.18,"latestTime":"17:39 EST","volume":12429,"amount":51953.29457399999,"timestamp":1765492780746},"delay":0,"floatShares":92240800,"shares":123877111,"eps":-1.441724,"marketStatus":"盘后交易","change":0.17,"latestTime":"12-11 18:01:15 EST","open":4,"high":4.19,"low":3.99,"amount":4567530.681532,"amplitude":0.049875,"askPrice":4.66,"askSize":100,"bidPrice":3.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.441724,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"listingDate":1589515200000,"exchange":"NYSE","adjPreClose":4.01,"preHourTrading":{"tag":"盘前","latestPrice":4,"preClose":4.01,"latestTime":"09:28 EST","volume":100,"amount":400,"timestamp":1765463336571},"postHourTrading":{"tag":"盘后","latestPrice":4.18,"preClose":4.18,"latestTime":"17:39 EST","volume":12429,"amount":51953.29457399999,"timestamp":1765492780746},"volumeRatio":0.544025,"impliedVol":1.627,"impliedVolPercentile":0.676},"requestUrl":"/m/hq/s/ADCT","defaultTab":"news","newsList":[{"id":"1122277823","title":"ADC Therapeutics 发布 Lotis-7 1B期临床试验的新数据，显示 Zynlonta® 与双特异性抗体联合使用的潜在最佳治疗方案，适用于复发/难治性大B细胞淋巴瘤患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1122277823","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122277823?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:30","pubTimestamp":1764765010,"startTime":"0","endTime":"0","summary":"ADC Therapeutics 发布 Lotis-7 1B期临床试验的新数据，显示 Zynlonta® 与双特异性抗体联合使用的潜在最佳治疗方案，适用于复发/难治性大B细胞淋巴瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"1195658704","title":"ADC Therapeutics 2025财年Q3业绩会总结及问答精华：ZENLATA临床进展与市场扩展潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1195658704","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195658704?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:21","pubTimestamp":1762784502,"startTime":"0","endTime":"0","summary":"ADC Therapeutics管理层强调ZENLATA在第三线以上DLBCL患者中的差异化治疗选择，并持续推进关键试验数据。管理层计划在2026年公布LOTUS V试验的顶线结果，并在2027年进行补充BLA提交。问题3：ZENLATA是否考虑进入DLBCL的一线治疗？ADC Therapeutics在2025财年第三季度通过降低运营成本和私募融资延长现金流，继续推进ZENLATA的临床试验和市场扩展。管理层对未来的市场潜力持乐观态度，预计ZENLATA将在DLBCL的第二线及以上治疗中实现显著的收入增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","ADCT"],"gpt_icon":0},{"id":"1166212373","title":"ADC Therapeutics SA：截至9月30日的三个月和九个月内，重组、减值及其他相关费用分别为40万美元和1350万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166212373","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166212373?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:39","pubTimestamp":1762778375,"startTime":"0","endTime":"0","summary":"ADC Therapeutics SA：截至9月30日的三个月和九个月内，重组、减值及其他相关费用分别为40万美元和1350万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2544817312","title":"加拿大皇家银行：维持ADC Therapeutics(ADCT.US)评级，由优于大市调整至优于大市评级, 目标价由8.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544817312","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544817312?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:04","pubTimestamp":1750428271,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持ADC Therapeutics(ADCT.US)评级，由优于大市调整至优于大市评级, 目标价由8.00美元调整至5.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/20220451211854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADC","ADCT","LENZ"],"gpt_icon":0},{"id":"2543548633","title":"Guggenheim：维持ADC Therapeutics(ADCT.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543548633","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543548633?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:24","pubTimestamp":1749824675,"startTime":"0","endTime":"0","summary":"Guggenheim：维持ADC Therapeutics(ADCT.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至10.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/13222451066588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADCT","ADC","LENZ"],"gpt_icon":0},{"id":"2518099672","title":"Adc Therapeutics Sa盘中异动 股价大跌5.16%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518099672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518099672?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:10","pubTimestamp":1741630242,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时10分，Adc Therapeutics Sa股票出现异动，股价急速跳水5.16%。截至发稿，该股报1.75美元/股，成交量14.2555万股，换手率0.15%，振幅4.35%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为0.69%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102104298a2d3e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102104298a2d3e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ADCT","BK4139"],"gpt_icon":0},{"id":"2517192786","title":"Adc Therapeutics Sa盘中异动 下午盘急速拉升5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192786?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:49","pubTimestamp":1741290558,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时49分，Adc Therapeutics Sa股票出现异动，股价快速上涨5.62%。Adc Therapeutics Sa股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为5163.60%、4474.05%、264.87%，振幅较大的相关个股有Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Tonix Pharmaceuticals Holding Corp.，振幅分别为172.51%、127.10%、71.44%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034918989eeb10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034918989eeb10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ADCT"],"gpt_icon":0},{"id":"2517941825","title":"Adc Therapeutics Sa盘中异动 股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517941825?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:17","pubTimestamp":1741191430,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时17分，Adc Therapeutics Sa股票出现异动，股价大幅跳水5.59%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为895.85%、291.89%、278.41%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001711abe9d15d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001711abe9d15d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADCT","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2516163203","title":"Adc Therapeutics Sa盘中异动 急速下挫5.68%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516163203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516163203?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:58","pubTimestamp":1741013906,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时58分，Adc Therapeutics Sa股票出现波动，股价大幅下跌5.68%。截至发稿，该股报1.66美元/股，成交量1.9903万股，换手率0.02%，振幅4.64%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为0.00%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225826a25d4829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225826a25d4829&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADCT","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2514863067","title":"Adc Therapeutics Sa盘中异动 快速上涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863067?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:17","pubTimestamp":1740590229,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时17分，Adc Therapeutics Sa股票出现波动，股价快速拉升5.13%。截至发稿，该股报1.64美元/股，成交量7.8446万股，换手率0.08%，振幅4.81%。Adc Therapeutics Sa股票所在的生物技术行业中，整体跌幅为0.03%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011710abde11c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011710abde11c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ADCT"],"gpt_icon":0},{"id":"2514201112","title":"Adc Therapeutics Sa盘中异动 早盘股价大跌5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201112?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:27","pubTimestamp":1740500854,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时27分，Adc Therapeutics Sa股票出现异动，股价快速跳水5.00%。截至发稿，该股报1.52美元/股，成交量7.8271万股，换手率0.08%，振幅4.32%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为0.35%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002734a253a15b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002734a253a15b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADCT","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2513729697","title":"Stephens & Co.：维持ADC Therapeutics(ADCT.US)评级，由增持调整至增持评级, 目标价由6.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729697","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513729697?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:22","pubTimestamp":1740403325,"startTime":"0","endTime":"0","summary":"Stephens & Co.：维持ADC Therapeutics(ADCT.US)评级，由增持调整至增持评级, 目标价由6.00美元调整至8.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212248352457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADCT","LENZ","ADC"],"gpt_icon":0},{"id":"2512166105","title":"Adc Therapeutics Sa盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166105?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:45","pubTimestamp":1739889906,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时45分，Adc Therapeutics Sa股票出现波动，股价大幅拉升5.00%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Solid Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为305.91%、111.39%、89.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.，振幅分别为41.79%、34.04%、26.83%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224506a24aafc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224506a24aafc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2511699767","title":"Adc Therapeutics Sa盘中异动 大幅拉升5.90%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511699767?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:45","pubTimestamp":1739544305,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时45分，Adc Therapeutics Sa股票出现波动，股价急速拉升5.90%。截至发稿，该股报1.71美元/股，成交量2.2044万股，换手率0.02%，振幅2.48%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为0.33%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422450698858d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422450698858d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADCT","BK4139","BK4505"],"gpt_icon":0},{"id":"2511573817","title":"Adc Therapeutics Sa盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511573817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511573817?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:37","pubTimestamp":1739468222,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时37分，Adc Therapeutics Sa股票出现异动，股价急速拉升5.41%。截至发稿，该股报1.56美元/股，成交量13.4904万股，换手率0.14%，振幅7.09%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为1.04%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214013702a244d156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214013702a244d156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADCT","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2510036339","title":"Adc Therapeutics Sa盘中异动 早盘股价大跌5.44%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510036339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510036339?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:19","pubTimestamp":1739290766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时19分，Adc Therapeutics Sa股票出现波动，股价急速跳水5.44%。截至发稿，该股报1.39美元/股，成交量22.0818万股，换手率0.23%，振幅4.83%。Adc Therapeutics Sa股票所在的生物技术行业中，整体跌幅为1.56%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212001926abcb1e06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212001926abcb1e06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2510089904","title":"Adc Therapeutics Sa盘中异动 下午盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510089904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510089904?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:04","pubTimestamp":1739214276,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时04分，Adc Therapeutics Sa股票出现异动，股价快速跳水5.30%。截至发稿，该股报1.43美元/股，成交量26.9099万股，换手率0.28%，振幅5.30%。Adc Therapeutics Sa股票所在的生物技术行业中，整体跌幅为0.76%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211030437961e3331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211030437961e3331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ADCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2509672382","title":"Adc Therapeutics Sa盘中异动 早盘急速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509672382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509672382?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:49","pubTimestamp":1738943385,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时49分，Adc Therapeutics Sa股票出现异动，股价快速下跌5.25%。Adc Therapeutics Sa股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Conduit Pharmaceuticals Inc.、Fibrobiologics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为4295.40%、149.43%、91.58%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、53.38%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234945961b46e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234945961b46e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADCT","LENZ","BK4505"],"gpt_icon":0},{"id":"2509888259","title":"Adc Therapeutics Sa盘中异动 临近收盘股价大涨5.15%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509888259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509888259?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:58","pubTimestamp":1738789108,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时58分，Adc Therapeutics Sa股票出现波动，股价急速拉升5.15%。截至发稿，该股报1.74美元/股，成交量33.8527万股，换手率0.35%，振幅4.85%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4732.99%、2454.33%、1790.53%，振幅较大的相关个股有Oragenics Inc.、Invivyd, Inc.、Transcode Therapeutics, Inc.，振幅分别为132.24%、108.79%、99.51%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045828abc3cc80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045828abc3cc80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2509915314","title":"Adc Therapeutics Sa盘中异动 大幅上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509915314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509915314?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:47","pubTimestamp":1738702038,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时47分，Adc Therapeutics Sa股票出现波动，股价快速拉升5.06%。Adc Therapeutics Sa股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1963.18%、995.00%、590.17%，振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为123.99%、72.26%、59.42%。Adc Therapeutics Sa公司简介：ADC Therapeutics SA是一家专注于肿瘤学商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504471896181184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504471896181184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","ADCT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adctherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":-0.0475},{"period":"3month","weight":0.2042},{"period":"6month","weight":0.1201},{"period":"1year","weight":0.1523},{"period":"ytd","weight":1.0151}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ADC Therapeutics SA于2011年6月6日根据瑞士法律注册成立。该公司是一家完全整合的商业阶段生物技术公司，通过下一代靶向抗体药物偶联物帮助改善癌症患者的生活。该公司的旗舰产品ZYNLONTA（loncastuximab tesirine或Lonca）于2021年4月23日获得FDA的加速批准，并在此后不久在美国上市，用于治疗经过两个或两个以上系统治疗的复发或难治性大B细胞淋巴瘤成人患者，包括未另行说明的弥漫性大B细胞淋巴瘤、由低级别淋巴瘤引起的DLBCL，以及高级别B细胞淋巴瘤。该公司的目标是将ZYNLONTA确立为三线+ DLBCL护理标准，同时探索ZYNLONTA在早期治疗和组合中的应用，以扩大市场机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.146727},{"month":2,"riseRate":0.6,"avgChangeRate":0.056374},{"month":3,"riseRate":0,"avgChangeRate":-0.185987},{"month":4,"riseRate":0.4,"avgChangeRate":-0.040442},{"month":5,"riseRate":0.4,"avgChangeRate":0.122666},{"month":6,"riseRate":0.5,"avgChangeRate":0.042888},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.072983},{"month":8,"riseRate":0.333333,"avgChangeRate":0.008214},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.079772},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.058531},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.016563},{"month":12,"riseRate":0.333333,"avgChangeRate":0.094909}],"exchange":"NYSE","name":"ADC Therapeutics SA","nameEN":"ADC Therapeutics SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADC Therapeutics SA(ADCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADC Therapeutics SA(ADCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADC Therapeutics SA,ADCT,ADC Therapeutics SA股票,ADC Therapeutics SA股票老虎,ADC Therapeutics SA股票老虎国际,ADC Therapeutics SA行情,ADC Therapeutics SA股票行情,ADC Therapeutics SA股价,ADC Therapeutics SA股市,ADC Therapeutics SA股票价格,ADC Therapeutics SA股票交易,ADC Therapeutics SA股票购买,ADC Therapeutics SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADC Therapeutics SA(ADCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADC Therapeutics SA(ADCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}